KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
KPRX on Nasdaq
Shares outstanding
3,640,761
Price per share
$2.80
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
616,169
Total reported value
$1,714,712
% of total 13F portfolios
0%
Share change
-315,674
Value change
-$910,084
Number of holders
17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% $1,095,537 365,179 ADAR1 Capital Management GP, LLC 30 Jun 2025
Nantahala Capital Management, LLC 10% 0% $1,018,394 +$160,860 363,712 +19% Nantahala Capital Management, LLC 30 Sep 2025
HIRSCHMAN ORIN 8.5% $843,332 255,555 Orin Hirschman 31 Dec 2024
Nantahala Capital Partners Limited Partnership 5.3% $569,115 189,705 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 08 Aug 2025
Alyeska Investment Group, L.P. 2.5% $249,572 75,628 Alyeska Investment Group, L.P. 31 Dec 2024
GOLDMAN SACHS GROUP INC 0% $429 130 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024

As of 30 Sep 2025, 17 institutional investors reported holding 616,169 shares of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX). This represents 17% of the company’s total 3,640,761 outstanding shares.

Top 21 Institutional Shareholders

The largest institutional shareholders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ADAR1 Capital Management, LLC 4.6% 167,941 +0.5% 0.05% $466,876
Nantahala Capital Management, LLC 4.3% 156,427 -26% 0.03% $434,867
Stonepine Capital Management, LLC 3.9% 140,598 -21% 0.32% $390,862
CITADEL ADVISORS LLC 1.2% 44,573 0% $124,804
DRW Securities, LLC 1% 36,865 0.01% $102,484
VANGUARD GROUP INC 0.57% 20,915 0% $58,562
GEODE CAPITAL MANAGEMENT, LLC 0.52% 18,853 +1.5% 0% $52,787
RENAISSANCE TECHNOLOGIES LLC 0.34% 12,400 0% $34,472
TWO SIGMA INVESTMENTS, LP 0.33% 11,984 0% $33,316
CITIGROUP INC 0.11% 3,884 +10997% 0% $10,875
UBS Group AG 0.04% 1,364 -92% 0% $3,792
SBI Securities Co., Ltd. 0.01% 256 0% 0% $712
BlackRock, Inc. 0% 58 0% 0% $161
BANK OF AMERICA CORP /DE/ 0% 25 +19% 0% $70
NewEdge Advisors, LLC 0% 22 0% 0% $61
OSAIC HOLDINGS, INC. 0% 2 0% 0% $5
Activest Wealth Management 0% 2 0% 0% $6
RAYMOND JAMES FINANCIAL INC 0% 0 -100% $0
Tower Research Capital LLC (TRC) 0% 0 -100% $0
Velan Capital Investment Management LP 0% 0 -100% $0
AIGH Capital Management LLC 0% 0 -100% $0

Institutional Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 616,169 $1,714,712 -$910,084 $2.78 17
2025 Q2 931,843 $2,683,707 -$1,054,952 $2.88 16
2025 Q1 1,285,403 $3,869,063 +$78,079 $3.01 18
2024 Q4 1,259,459 $4,164,082 +$76,847 $3.30 16
2024 Q3 1,213,569 $4,441,661 +$905,961 $3.66 18
2024 Q2 966,044 $4,057,360 +$4,057,360 $4.20 15